Long-Term Health Outcomes of Surgical Menopause

Similar documents
BSO, HRT, and ERT. No relevant financial disclosures

Key Recommendations. Gynecologic management of women with inherited risk of gynecologic cancer

Tumori eredofamiliari: sorveglianza di donne ad alto rischio

Surgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

Menopause Symptoms and Management: After Breast Cancer

Risk-reducing surgery and hormones

patient education Fact Sheet

Inherited Ovarian Cancer Diagnosis and Prevention

Genetic Determinants, Risk Assessment and Management

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

Surgery to reduce the risk of ovarian cancer

Key Recommendations. Gynecologic management of women with inherited risk of gynecologic cancer. HBOC related genes. I have nothing to disclose

Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?

Ovarian Cancer Causes, Risk Factors, and Prevention

patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015

Management of BRCA mutation carriers

06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:

--- or not, and do we need to come up with newer strategies for ovarian cancer screening.

Is It Time To Implement Ovarian Cancer Screening?

BRCA mutation carrier patient: How to manage?

Christine Garcia, MD 1, Liisa Lyon, MS 2, Ramey D. Littell, MD 1 and C. Bethan Powell, MD 1

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Screening tests. When you need them and when you don t

What is the gynecologist s role in the care of BRCA previvors?

THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES

OVARIAN CANCER Updates in Screening, Early Detection and Prevention

Ask the Experts Obstetrics & Gynecology

University Gynecologic Oncology Associates

Managing the adnexae at the time of hysterectomy for benign gynaecological disease

Primary Care Approach to Genetic Cancer Syndromes

1. Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45

EVALUATION OF WOMEN FOLLOWING HYSTERECTOMY WITH AND WITHOUT CONSERVATION OF OVARIES

Menopause and Cancer risk; What to do overcome the risks? Fatih DURMUŞOĞLU,M.D

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School

This includes bone loss, endometrial cancer, and vasomotor symptoms.

Welcome! Here s our agenda for today:

Why do I need any hormone replacement? What is Menopause? What symptoms are treated by estrogen Injections?

BRCA2 gene. Associated Syndrome Name: Hereditary Breast and Ovarian Cancer syndrome (HBOC) BRCA2 Summary Cancer Risk Table. BRCA2 gene Overview

Both type I and type II tumors develop from extraovarian tissue that implants on the ovary. Both for LGSC and HGSC, the fallopian tube appears to be

Hormone Treatments and the Risk of Breast Cancer

BRCAplus. genetic testing for hereditary breast cancer

X-Plain Ovarian Cancer Reference Summary

What You Need to Know About Ovarian Cancer

Finding Our Reasons to Choose Estrogen PRE- HRT. Learning Objectives. Disclosure. Learning Objectives. Replacement Therapy. For Previvors 6/1/17

Inherited Breast and Ovarian Cancer: 20 Years of Progress and Future Directions

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

Ohio Northern University HealthWise. Authors: Alexis Dolin, Andrew Duska, Hannah Lamb, Eric Miller, Pharm D Candidates 2018 May 2018

Utilization of BRCA Testing. Breast and Ovarian Cancer in Texas

Hormonal Control of Human Reproduction

Patient Education. Breast Cancer Prevention. Cancer Center

Jill Stopfer, MS, CGC Abramson Cancer Center University of Pennsylvania

Genetic Screening Visit

Biology Response Controversies and Advances

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families

Hereditary Gynecologic Cancer 15 Years of Progress

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

Partners: Introductions: Dr. Carolyn Johnston Deanna Cosens & Ann Garvin. Ovarian Cancer and Primary Care July 16, :00 9:00am EST 7/16/2014

Policy #: 259 Latest Review Date: November 2009

4:00 into mp3 file Huang_342831_5_v1.mp3

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018

Osteoporosis Ask The Expert

Christine Herde, MD, FACOG

Explaining Personalized Medicine in Cancer and Some Tips for a Healthier Life. Petra Ketterl, MD Integrative Medicine and Cancer Care

FAQ-Protocol 3. BRCA mutation carrier guidelines Frequently asked questions

Screening in Ovarian Cancer: Any closer to the Holy Grail?

The Estrogen Question

Menopause and HIV. Together, we can change the course of the HIV epidemic one woman at a time.

Palm Beach Obstetrics & Gynecology, PA

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Oophorectomy or salpingectomy which makes more sense?

Clinical options for mutations of BRCA 1/2 genes. Ioannis Th. Natsiopoulos Breast surgeon

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

Genetic Risk Assessment for Cancer

Result Navigator Positive Test Result: MSH6

Genetics of Breast and Ovarian Cancer: Risk Assessment, Screening, and Risk Reduction

Cancer Conversations

Aromatase Inhibitors & Osteoporosis

BIOLOGICAL D E T E R M I N AN T S O F H E AL T H ( )

4.7 Studies of Quality Holy Cross Hospital Bone Health Early Stage I ER/PR Positive Breast Cancer Patients December 13, 2017

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine

Hormonal Therapies for Breast Cancer. Westmead Breast Cancer Institute

North American Menopause Society (NAMS)

Disclosure. Gynecologic Cancer Genetics. Audience response. Audience response. What was the result? 47%

OBJECTIVES 8/25/2017. An attempt to organize the chaos

Updates in Gynecologic Oncology. Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018

Patient Health Forms

Chapter 39: Exercise prescription in those with osteoporosis

Information leaflet for women with an increased lifetime risk of breast and ovarian cancer. Hereditary Breast and Ovarian Cancer (HBOC)

Result Navigator. Positive Test Result: RAD51C. After a positive test result, there can be many questions about what to do next. Navigate Your Results

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology

MENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?

SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer

How common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.

Interpretation of p53 Immunostains. P53 Mutations are Ubiquitous in High Grade Serous Carcinoma. Diffuse strong positive nuclear staining

This information explains the advice about familial breast cancer (breast cancer in the family) that is set out in NICE guideline CG164.

Transcription:

Long-Term Health Outcomes of Surgical Menopause Vanessa Jacoby, MD, MAS Associate Professor Obstetrics, Gynecology, and Reproductive Sciences University of California, San Francisco

None Disclosures

Overview Overview of surgical menopause for women with HBOC Impact of surgical menopause on Heart health Bone health and risk of fractures Cognitive ability/memory

What is natural menopause? Natural menopause. --No menstrual period for 1 year --Average age is 51 years

Slow and Gradual Hormone Changes Estrogen

What is surgical menopause? Estrogen Progesterone Testosterone

Ovarian Hormones in Menopause 561 women, age 50-90 Ovaries present No Ovaries Laughlin et al, 2000, Jo Clin Endo and Metab

Surgical menopause: Hysterectomy Total Hysterectomy: No periods, but not menopause by hormones

Surgical menopause: Hysterectomy Supracerical (subtotal) Hysterectomy: No periods, but not menopause by hormones

Surgical menopause: Oophorectomy Bilateral Salpingo-oophorectomy (BSO): Removal of both fallopian tubes and ovaries

Surgical menopause: Oophorectomy Bilateral Salpingo-oophorectomy (BSO): No periods and menopause by hormones

Surgical menopause: RRSO Bilateral Salpingo-oophorectomy (BSO) for women with HBOC is.. Risk Reducing Salpingo-oophorectomy (RRSO)

Surgical menopause: Hysterectomy Ovary Fallopian tube Ovary

Surgical menopause: RRSO Questions?

RRSO versus Natural Menopause Natural Menopause RRSO Age 51 35-45 Onset gradual sudden Hormone level Low Absent Treatment for symptoms Other Hormones common Many seek nonhormonal treatment May have other surgery, diagnosis of cancer

RRSO Benefits Significant decrease in risk of cancer Ovarian (90%) Fallopian tube Peritoneal Breast (up to 75%)

National Guidelines: Age at RRSO BRCA 1 BRCA 2 Lynch Syndrome BRIP1, RAD51C, RAD 51D 35-40 years 40-45 years 35-40 years Consider 45-50 years

Risk Reduction: With or Without Hysterectomy? Hysterectomy with RRSO 1. Increased risk of uterine cancer (e.g. Lynch Syndrome) 2. Other gynecologic reason for hysterectomy 3. Plan to take tamoxifen 4. Plan to take estrogen after surgery, hope to avoid progesterone

Risk Reduction: With or Without Hysterectomy? If using hormones to help with menopause symptoms Estrogen AND Progestin to avoid uterine cancer Estrogen only is OK

Salpingectomy Removal of Fallopian Tubes only

Salpingectomy Evidence that some ovarian cancer may begin in fallopian tube but NCCN Guidelines: salpingectomy alone is not the standard of care and is discouraged outside a clinical trial

Who undergoes RRSO? 50% of women with known BRCA mutations More likely if -Have had breast cancer -Family history of cancer -Age >45 years

National Guidelines for Non-Cancer Outcomes after RRSO Society for Gynecologic Oncology: limited information is available regarding management of women following RRSO National Comprehensive Cancer Network (NCCN): Discuss medical issues during RRSO counseling, but what health issues or risks should be addressed?

Surgical menopause: RRSO Questions?

Noncancerous Consequences of RRSO

Noncancerous Consequences of RRSO Challenges: A lot of studies... ---use data from LOW RISK population undergoing hysterectomy ---evaluate health many years AFTER RRSO ---do not account for use of hormone therapy Very difficult to be certain about health after RRSO. More studies needed!

Impact of Premature Menopause Spontaneous menopause occurs <40 years INSUFFICIENCY

Impact of Premature Menopause INSUFFICIENCY Increased risk of. Heart disease and death from heart disease Osteoporosis (thin bones) and fractures Impaired cognitive function

Impact of Premature Menopause INSUFFICIENCY BUT.. Is this really similar to RRSO for HBOC?

Oophorectomy by Age at Hysterectomy, 2005 Percent 80 70 60 50 40 30 20 10 0 18-34 35-39 40-44 45-49 50-54 >55 Age Jacoby et al, Obstet and Gyn 2009

Oophorectomy in LOW risk women Definite risks of BSO NONE Possible risk of BSO Coronary heart disease: Osteoporosis/fracture: Sexual functioning/ QOL: Dementia: Death:

Oophorectomy in LOW risk women Definite risks of BSO NONE Possible risk of BSO Coronary heart disease: Inconclusive data Osteoporosis/fracture: Inconclusive data Sexual functioning/ qol: Inconclusive data Dementia: Inconclusive data Death: Inconclusive data

Oophorectomy with Hysterectomy in LOW risk women Different population because.. Reason for hysterectomy may cause health risks Hysterectomy alone may have health risks Hormone use very common

Oophorectomy with Hysterectomy in LOW risk women Different population because.. BRCA mutation may be a risk factor for noncancerous conditions No DNA repair Heart disease Diabetes High cholesterol

Surgical menopause: RRSO Questions?

Health Outcomes after RRSO: Heart disease

Menopause and Heart Disease Menopause is risk factor for heart attacks MAYBE!

Menopause and Heart Disease Maintains endothelial function (lining of blood vessels) Increase in insulin cell response Suppresses cholesterol levels

Heart Health Disease Number of deaths/year Cardiovascular disease 459,096 Lung Ca 70,880 Breast 40,460 Colorectal 26,180 Pancreatic 16,530 Ovary 15,280

Heart Health: RRSO The study we WISH we had 1, 2, 3, 5, 10 years: Check heart health Before RRSO: Check heart health

Heart Health: RRSO The studies we actually have Check heart health many years AFTER RRSO Maybe heart disease or protective factors occurred prior to RRSO

Heart Health: RRSO The study we actually have Women in Norway who had RRSO compared to NO RRSO, more likely to: --have Metabolic Syndrome (high blood pressure, high cholesterol, high blood sugar) --increased risk of heart disease and diabetes But No RRSO group was not with BRCA mutations! Michelsen, et al, Int J Gynecol Ca 2010

Heart Health: RRSO Summary Premature natural menopause increases risk Oophorectomy at time of hysterectomy may increase risk No completed, well-designed studies of women with BRCA mutations to asses RRSO heart risks

Surgical menopause: RRSO Questions?

Bone Health Estrogen keeps bones strong!

Bone Health Rapid decrease in bone density at menopause

Bone Health: RRSO The studies we actually have Check bone density many years AFTER RRSO Maybe poor density occurred prior to RRSO.but probably not!

Bone Health after RRSO RRSO generally found to decrease bone density Osteopenia (bone thinning) 30-72% in studies Osteoporosis (low bone mass/skeletal fragility) and fracture risk RRSO <50 years=higher risks for osteopenia Estrogen use may decrease risk of osteopenia, but some studies have found persistent osteopenia even with use

Bone Health after RRSO Questions remain Should I get a DEXA (bone density scan) and if so, when? How can I prevent bone thinning?

Bone Health after RRSO Recommendations for post-menopausal women: Vitamin D 800 IU +1,200mg elemental Calcium daily Weight-bearing exercise three times/week --Jogging is not better than walking. Do what you enjoy! Smoking cessation --smoking increases fracture risk and decreases bone density

Surgical menopause: RRSO Questions?

Cognitive function and Estrogen Strong biologic evidence that estrogen supports cognitive function: --estrogen receptors in the brain --stimulates nerve cells to communicate --protects nerve cells from toxins

Cognitive function and Estrogen Oral estrogen + progesterone INCREASE risk for cognitive impairment (age 65-79 years)

RRSO: Cognitive function No studies of RRSO

Memory and Oophorectomy Small studies on memory.none in U.S. population Some memory tests worse in women with surgical versus natural menopause who did NOT take hormone therapy (100 women in Italy, average age 51) Memory declined 3-6 months after hysterectomy/bso compared with control group (50 women in Egypt, average age 41) Nappi et al, Gynecol Obstet Invest 1999 Farrag et al, dement Geriatr Cogn Disord 2002

BSO and Dementia Study Mayo Cohort Rocca WA et al Neurology 2007 Risk of impaired cognitive function or dementia with BSO? NO for BSO overall YES for some groups age 43-48 BSO no Estrogen to age 50 Rancho Bernardo Kritz-Silverstein J Am Geriatr 2002 NO

Next Steps for Non-Cancerous Outcomes 1.Conduct better studies! 2.Change guidelines on post-rrso management When to order DEXA? When to check lipids? 3.Aim is to support long-term survival and inform decision-making for RRSO